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Purpose: To compare axial length (AL) and subfoveal choroidal thickness (SFCT) between individuals
with age-related macular degeneration (AMD) and controls with no lesions.
Methods: This was a case-control study. In total, 853 eyes of 484 patients (>65 years), including 397 eyes
at various AMD stages and 456 eyes with no fundus lesions (controls) were recruited. Using color fundus
photography, eyes were grouped according to AMD degree. AL was automatically measured using IOL
Master and SFCT was manually measured by two independent observers. The associations among age,
AL, SFCT, and each AMD grade were analyzed.
Results: Out of 853 eyes, 456 had no lesions, 217 contained drusen only, 134 had early AMD, and 46 had
late AMD. The eyes with late AMD were older (p ¼ 0.007) and had longer AL (p < 0.001) and thinner SFCT
(p < 0.001) compared with groups of no fundus lesions, drusen only, and early AMD. SFCT in eyes with
late AMD decreased by 19.20 mm (p ¼ 0.049), 24.78 mm (p ¼ 0.029), and 15.56 mm (p ¼ 0.162) compared
with groups of no fundus lesions, drusen only, and early AMD, respectively. SFCT decreased by 14.18 mm/
mm increase in AL (p < 0.001). The odds ratio (OR) for late AMD by longer AL (25 mm) and thinner SFCT
(<240 mm) was 4.54 (c2 ¼ 9.36; p ¼ 0.002) and 4.86 (c2 ¼ 17.62; p < 0.001), respectively, and was 9.57
(c2 ¼ 18.07; p < 0.001) when both AL  25 mm and SFCT < 240 mm.
Conclusion: Eyes with late AMD have distinct reduced SFCT and elongated AL. Eyes with thinner SFCT and
longer AL showed high ORs for late AMD and even higher ORs when both factors were simultaneously
present. These ﬁndings illustrate the crucial pathophysiological role of these two important ocular fac-
tors and arouse our attention to patients with both characteristics, especially in Asian countries where
the prevalence of myopia are disturbingly high.
Copyright © 2015, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Age-related macular degeneration (AMD) is a leading cause of
blindness in the elderly,1 and is the most common cause of legal
blindness in the Western world and in industrialized nations.2e7f interest and no proprietary
logy, Chang Gung Memorial
ad, PuTzu City, Chiayi County
cgmh.org.tw (C.-H. Lai).
ciety of Taiwan. Published by ElsevAMD can lead to loss of central vision; it can be associated with
several environmental factors8,9 including cigarette smoking,3,10
higher body mass index,11,12 and dietary carotenoids.13,14 A ge-
netic effect was suggested on the basis of clinical observations,
familial aggregation, and linkage studies,15,16 and has been
conﬁrmed with studies showing the associations between AMD
and several genetic loci.17
Besides the genetic and environmental factors, previous
population-based studies among Caucasians have identiﬁed the
possible associations of various ocular factors with AMD.18e20 The
Los Angeles Latino Eye Study also evaluated the associations be-
tween various ocular factors and AMD in Latinos. These factorsier Taiwan LLC. All rights reserved.
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depigmentation, and longer axial length (AL).21 Some early histo-
logical studies22,23 showed a decrease in the density of choroidal
blood vessels and thinning of the choroid in AMD eyes. Some small
scale image studies24,25 also conﬁrmed decreased subfoveal
choroidal thickness (SFCT) in exudative AMD eyes. The choroidal
circulatory status seems to play an important role. For example, the
ﬁndings of choroidal hypoperfusion were seen on indocyanine
green angiography in eyes with neovascular AMD.26 It is reasonable
to assume that the disruption of the integrity of the choroidal cir-
culation is part of the pathophysiology of wet AMD. Choriocapillaris
dysfunction and insufﬁcient blood supply to the RPE cells may
allow the RPE cells to be more prone to harmful oxidants or insults;
this initiates the accumulation of waste within Bruch's membrane,
resulting in the progression of AMD.27,28
Although anatomical choroid thickness is not necessarily
indicative of choroidal blood volume, ﬂow, and function, mea-
surement of SFCT is currently the most rational and accessible
method to evaluate choroidal function. To the best of our knowl-
edge, this study is the largest population-based survey comparing
SFCT and AL both together in normal eyes and in eyes at different
stages of AMD in an Asian population.We analyzed the relationship
between age, AL, and SFCT in different groups. All of these factors
may play a crucial pathophysiological role in the development of
late AMD in aging people.
2. Methods
This study is a case-control observational study based on our
prior population-based cross-sectional study, the Puzih Eye
Study.29 From January 2010 toMarch 2012, a total of 708 volunteers
(aged > 65 years) who lived in Puzih City participated in the Puzih
Eye Study. Puzih is also the area with the highest concentration of
aging population in Taiwan.
The study adhered to the Declaration of Helsinki, and ethics
approval was obtained from the Institutional Review Board of
Chang GungMemorial Hospital at Chiayi, Taiwan.Written informed
consent was obtained from all participants after a verbal explana-
tion by study researchers.
2.1. Patient selection and grouping
Among the 708 volunteers, 680 (96.04%) had at least one fundus
photograph of either eye, whereas 673 (95.05%) had recognizable
fundus photographs. After excluding eyes with retinopathy or
maculopathy other than AMD (e.g., diabetic retinopathy, retinal
vessel occlusion disease, high myopic maculopathy, and polypoidal
choroidal vasculopathy), 853 eyes from 484 patients using qualiﬁed
optical coherence tomography (OCT) images were enrolled in our
present study. The 853 eyes were grouped using color fundus
photographs according to the different stages of AMD: no fundus
lesions, drusen only, early AMD, and late AMD (Fig. 1).
The grading of the AMD stage was determined by two inde-
pendent retinal specialists, according to theWisconsin Age-Related
Maculopathy Grading System,30 using the color fundus photograph
that had been taken using a fundus camera (CF-60UD, Canon Inc,
Tokyo, Japan). The two specialists were masked from all general
data for the volunteers; all equivocal photos were reviewed
together with senior retina specialists.
2.2. Parameters measurement
AL of each eye was measured using optical biometry (IOL Mas-
ter; Zeiss, Jena, Germany) for each eye by averaging ﬁve measure-
ments. SFCT was manually measured by two observers using 1-lineraster scans OCT image (Stratus OCT, Carl Zeiss Meditec, Inc, Dublin,
CA, USA) taken through the foveal center horizontally. The sub-
foveal choroid was deﬁned as the choroid beneath the concave
central retinal depression 1500 mm in diameter. A single choroidal
thicknessmeasurement was obtained for the horizontal raster from
the outer border of the RPE to the inner scleral border. The manual
caliper was used to sequentially measure 250-mm distances in both
radial directions encompassing 1500 mm centered on the foveola by
each observer and the average of these measurements were
calculated as SFCT (Fig. 2). The observers were masked from pa-
tients' clinical data. Intraobserver/interobserver repeatablility was
also calculated.
2.3. Statistical analysis
One-way analysis of variance and post-hoc test (Scheffe's pro-
cedure) were used to calculate and compare the age, AL, and SFCTof
each AMD-grading group. The association between age and AL, age
and SFCT, and AL and SFCT were analyzed using univariate
regression, and the Pearson's correlation coefﬁcient was calculated.
Using multivariate regression, the effect on SFCT by age, AL, and
AMD grading was analyzed. Finally, the odds ratio (OR) for late
AMD with a certain cut-off value (22 mm and 25 mm of AL, and
240 mm of SFCT) was calculated. The generalized estimating equa-
tion model was used to estimate the strength of the relationship
between the outcome and the risk factors, while appropriately
taking into account the magnitude of the correlation between
fellow eyes.19,31 A p value 0.05 was considered statistically sig-
niﬁcant. All statistics were calculated using SPSS version 16.0 (SPSS
Inc, Chicago, IL, USA).
3. Results
The study enrolled 853 eyes from 484 patients, including 456
eyes with no lesion, 217 with drusen only, 134 with early AMD, and
46 with late AMD. Four hundred and eighty-three eyes (56.6%)
were of male participants. The mean age of the participants was
73.51 ± 6.02 years (range, 65e90 years). The mean AL and SFCT
were 23.42 ± 1.22 mm and 282.7 ± 45.16 mm (Table 1).
3.1. Analysis between age, AL, and SFCT
The single linear regression analysis of age, AL, and SFCT
revealed no signiﬁcant correlation between age and SFCT
(r ¼ 0.002; p ¼ 0.967), a very weak negative correlation between
age and AL (r ¼ 0.077; p ¼ 0.043; Figs. 3A and 3B), and a
moderately negative correlation between AL and SFCT (r ¼ 0.455;
p < 0.001). The linear equation of AL versus SFCT showed that SFCT
decreased by 16.15 mm for every mm increase in AL (Fig. 4).
In a stepwise multiple regression model analysis of the effect on
SFCT, AL had the most effect on SFCT after adjustment for age and
AMD grading; SFCT decreased by 14.18 mm for everymm increase in
AL (p < 0.001). Age showed a nonsigniﬁcant effect, whereas SFCT
increased 0.55 mm for each additional year of age (p ¼ 0.082).
3.2. Age, AL, and SFCT of each subgroup
The mean age in the late AMD group was 76.73 ± 6.32 years,
which was higher than that in the other groups (p ¼ 0.007). The
mean AL in the late AMD group (24.32 ± 2.88 mm) was longer than
that in the other groups (p < 0.001). The mean SFCT in the late AMD
group (250.7 ± 68.2 mm) was thinner than that in the other groups
(p < 0.001). The mean SFCT in the no lesions, drusen only, and early
AMD groups were 282.2 ± 42.5 mm, 292.1 ± 44.1 mm, and
280.5 ± 40.7 mm, respectively. There were no signiﬁcant differences
Fig. 1. Flow chart of patient selection and grouping. AMD ¼ age-related macular degeneration; OCT ¼ optical coherence tomography.
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group (Table 1).3.3. Analysis of SFCT and AL between late AMD and other subgroups
After adjusting for age and AL, SFCT in the late AMD group
decreased by 19.20 mm (p ¼ 0.049), 24.78 mm (p ¼ 0.029), and
15.56 mm (p ¼ 0.162) compared with the no lesions, drusen only,
and early AMD groups, respectively (Table 2).
OR for late AMD by AL and SFCT was analyzed using a certain
cut-off value. For analysis of shorter AL, we considered AL as the
mean e 1 standard deviation (SD) ¼ 23.42 e 1.22 ¼ 22.20 (mm),
and we set the cut-off value at 22 mm for convenience. Likewise,
we accepted the longer AL cut-off value of 25 mm as the mean þ 1
SD ¼ 24.67 (mm). The cut-off value of 240 mm for thinner SFCT was
used because the mean e 1 SD ¼ 282.745.2 ¼ 237.5 (mm). Using
these cut-off values, OR for the late AMD groupwas 4.54 [c2¼ 9.36,p ¼ 0.002; 95% conﬁdence interval (CI), 1.72e11.99] when
AL  25 mm and was 4.86 (c2 ¼ 17.62, p < 0.001; 95% CI,
2.32e10.18) when SFCT < 240 mm. OR was as high as 9.57
(c2 ¼ 18.07, p < 0.001; 95% CI, 3.38e27.12) when the patients had
both AL  25 mm and SFCT < 240 mm. AL measurements that are
<22 mm have a nonsigniﬁcant OR of 1.41 (c2 ¼ 0.193, p ¼ 0.661;
95% CI, 0.30e6.58; Table 3).4. Discussion
In our study, the mean SFCT was 282.7 ± 45.2 mm for the no
lesion group, which was similar to other studies. However, there is
a remarkable variation among these studies. A mean SFCT from
261.93 ± 88.42 mm to 354 ± 111 mm in healthy controls were
observed in different researches.32e36 The variation in choroidal
thicknesses among different studies may be due to many factors,
including different OCT models, different light source wavelengths,
Fig. 2. Example of measurement of subfoveal choroidal thickness. A one-line raster scan optical coherence tomography image was taken through the foveal center horizontally. The
subfoveal choroid was deﬁned as the choroid beneath the concave central retinal depression 1500 mm in diameter. A single choroidal thickness measurement was obtained for the
horizontal raster from the outer border of the retinal pigment epithelium to the inner scleral border. The manual caliper was used to sequentially measure 250-mm distances in both
radial directions (total of 7 measurements/patient) by two independent observers. The average of these measurements was calculated as subfoveal choroidal thickness. As shown in
this patient, the subfoveal choroidal thickness was 342 mm.
Table 1
The average age, axial length, and subfoveal choroidal thickness in each group.
Total No lesion Drusen only Early AMD Late AMD pa
Eyes (n) 853 456 217 134 46 e
Age (y)b 73.51 ± 6.02 73.09 ± 5.84 72.56 ± 5.78 73.84 ± 6.01 76.73 ± 6.32c 0.007
AL (mm)b 23.42 ± 1.22 23.43 ± 1.04 23.32 ± 1.11 23.26 ± 0.9 24.32 ± 2.88c 0.001
SFCT (mm)b 282.7 ± 45.2 282.2 ± 42.5 292.1 ± 44.1 280.5 ± 40.7 250.7 ± 68.2c 0.001
AL ¼ axial length; AMD ¼ age-related macular degeneration; SFCT ¼ subfoveal choroidal thickness.
a One-way analysis of variance between different age-related macular degeneration grading groups.
b Data are presented as the mean ± standard deviation.
c Group that was signiﬁcantly different from other groups using a post-hoc test (Scheffe).
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races, patient groupings, refractive errors (REs), and ALs. The visi-
bility of the choroidal-scleral interface (CSI) by time-domain OCT
also has an unignorable inﬂuence in the measurement of choroidal
thickness. Time-domain OCT has a slower scanning speed and
lower resolution that make interpreting the CSI more difﬁcult. As
shown in Fig. 1, we excluded 123 eyes without available OCT im-
ages. Among these eyes, 29 eyes had no OCT image due to severe
lens andmedia opacity and 94 (9.6%) eyes had ill-deﬁned CSI. In our
study, the intraobserver interclass coefﬁcient was 0.853 and the
interobserver/intraobserver interclass coefﬁcient was 0.726, which
were acceptable repeatability.4.1. Age and choroidal thickness
In many studies, age had a signiﬁcant negative correlation with
choroid thickness. It is more prevalent in participants who have a
wider range of age.
Using enhanced depth imaging-OCT, Ding et al32 measured
choroidal thickness in a population of 210 healthy volunteers
whose mean age was 49.73 ± 17.89 years (range, 20e85 years). The
correlation analysis showed that SFCT negatively correlated with
age (r¼0.474; p < 0.001). Ikuno et al's36 study involving 43 young
and healthy Japanese volunteers (mean age, 39.4 ± 16.0 years;
range, 23e88 years) also showed a borderline signiﬁcant negative
correlation between age and SFCT (p ¼ 0.07; y ¼ 1.4x þ 410.6;
r2¼ 0.04), i.e., a reduction of 14 mm every decade. Shin et al33 founda moderate negative correlation (r ¼ 0.61; p < 0.001) in 34 pa-
tients (average age, 51.1 years; range, 22e78 years).
Our study showed a very weak negative and insigniﬁcant cor-
relation between age and SFCT (r ¼ 0.002; p ¼ 0.967) and a
borderline positive relationship in the stepwise analysis (coefﬁcient
B ¼ 0.55; r ¼ 0.082). Our population consisted of an older age
group, who were all aged < 65 years within a narrow distribution
(mean, 73.51 ± 6.02 years; range, 65e90 years). Therefore, the ef-
fect of aging in SFCT is less signiﬁcant in our study populationwhen
it is not compared with younger groups. It is more meaningful
when comparing the old with the young of the same group.
However, the role of thinner SFCT and longer AL can be observed
more clearly without the inﬂuence of age.4.2. AL and choroidal thickness
AL was the most important factor inﬂuencing choroidal thick-
ness as observed in our study. SFCT decreased as AL elongated as
found by single variation linear regression. After adjustment for age
and AMD grading using a stepwise multiple regression, SFCT
decreased by 14.18 mm for each mm increase in AL (p < 0.001).
This result is similar to that of Flores-Moreno et al37 who
investigated choroidal thickness in highly myopic eyes and healthy
eyes. Choroidal thickness in highly myopic eyes was thinner
(115.56 ± 85.3 mm) than that in controls (257.4 ± 99.3 mm)
(p < 0.001, Mann-Whitney U-test); for each additional mm increase
in AL, choroidal thickness decreased by 25.91 mm in highly myopic
Fig. 3. (A) Scatterplot of subfoveal choroidal thickness with age, showing the subfoveal choroidal thickness with age in this series of all eyes (r ¼ 0.0016, p ¼ 0.967); (B) scatterplot
of axial length with age, showing the axial length with age in this series of all eyes (r ¼ 0.0775, p ¼ 0.043).
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AL is the single most important ocular factor that can affect
choroidal thickness.
4.3. Choroidal thickness and AMD
Before OCTwas available for clinic practice, in-vitro evidence of a
thinner choroid in AMD patients was reported in 1976. Sarks22
conducted a histological study on 378 eyes from patients (age
range, 43e97 years) whosemaculae had presentedwith a variety ofclinical appearances. He found that thinning was associated with
increasing age and in those with all stages of AMD.
McLeod et al23 used an image analysis technique for quantifying
pathological changes in RPE and choriocapillaris in the eyes of two
AMD and one normal control donor. The study demonstrated a
large area in the posterior pole, with very few RPE cells (90% loss of
RPE); there was a 30e50% decrease in the density of choroidal
blood vessels in this area in the eye of Case 1, and an even greater
decrease in the eye of Case 2 (53% decrease in the submacular re-
gion) compared with that in the control eye.
Fig. 4. Scatterplot of axial length and subfoveal choroidal thickness of all eyes in this series shows a signiﬁcant negative correlation (r ¼ 0.455, p < 0.001; y ¼ 16.15x þ 549.7;
R2 ¼ 0.207).
Table 3
Odds ratio of late age-related macular degeneration by axial length and subfoveal
choroidal thickness.
OR c2 p 95% CI
AL
< 22 mma 1.41 0.193 0.661 (0.30, 6.58)
 22 mm 1 d d d
AL
 25 mmb 4.54 9.36 0.002 (1.72, 11.99)
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and, hence, thinner choroidal thicknesses are more susceptible to
developing AMD with increasing age.
In our study, the mean SFCT of the late AMD group was signif-
icantly less than that of the other groups (p < 0.01). In a multiple
regression model analysis after adjustment for age and AL, SFCT
was also less when compared with the no lesion, drusen only, and
early AMD groups, with a decrease of 19.20 mm, 24.78 mm, and
15.56 mm, respectively. The more signiﬁcantly thinner choroidal
thickness in the late AMD group and the less signiﬁcant association
between early AMD and normal controls were also observed in
other small scale studies.24,25
Furthermore, as a population-based study, we also analyzed OR
for late AMD between eyes with SFCT below the mean e 1 SD
(<240 mm) and eyes with SFCT  240 mm; the results showed a
signiﬁcantly high OR of 4.86. In light of numerous histologic and
in vivo evidence and a clear statistical relationship between
choroidal thickness and AMD, it is reasonable to believe that
thinner choroidal thickness played a large part in the development
of late AMD.
4.4. AL and AMD
The association between AL and AMD has been inconclusive to
date. Our present study revealed that the late AMD group has aTable 2
Multivariate analysis of associations between subfoveal choroidal thickness and
ocular and general parameters.
Parameter B factor p 95% CI
Age (y) 0.55 0.082 (e0.07, 1.18)
Axial length (mm) 14.18 < 0.001 (e17.82, 10.54)
Disease stage (compared with late AMD group)
No lesion 19.20 0.049 (4.67, 39.09)
Drusen only 24.78 0.029 (6.59, 46.97)
Early AMD 15.56 0.162 (e2.238, 37.35)
AMD ¼ age-related macular degeneration; CI ¼ conﬁdence interval.longer mean AL (24.32 ± 2.88 mm; one-way analysis of variance:
p< 0.001) comparedwith the other groups. The eyes with longer AL
(25 mm) also have higher odds (OR: 4.54) of late AMD than eyes
with AL < 25 mm.
Ikuno36 investigated the association of AL and age-related
maculopathy/AMD in a study that included 663 randomly
selected people aged> 65 years. Therewas no signiﬁcant difference
in the refractions or ALs among the groups with different stages of
age-related maculopathy. The Los Angeles Latino Eye Study21 re-
ported that longer AL (mm) was associated with decreased odds of
soft drusen but increased odds of geographic atrophy [(OR ¼ 0.8;
95% CI, 0.7e0.9), (OR ¼ 0.7; 95% CI, 0.5e0.9), respectively].
The role of AL in AMD is paradoxical and is not as predominant
as it is in high myopic maculopathy as mentioned in current< 25 mm 1 d d d
SFCT
< 240 mmc 4.86 17.62 <0.001 (2.32, 10.18)
 240 mmc 1 d d d
AL  25 mm and SFCT < 240 mm 9.57 18.07 <0.001 (3.38, 27.12)
AL < 25 mm or SFCT  240 mm 1 d d d
AL ¼ axial length; CI ¼ conﬁdence interval; OR ¼ odds ratio; SD ¼ standard devi-
ation; SFCT ¼ subfoveal choroidal thickness.
a Axial length below mean  1 SD ¼ 23.42  1.22 ¼ 22.20 mm, use the cut off
value of 22 for convenience.
b Axial length above mean þ 1 SD ¼ 23.42 þ 1.25 ¼ 24.67 mm, use the cut off
value of 25 for convenience.
c Subfoveal choroidal thickness below mean  1 SD ¼ 282.7  45.2 ¼ 237.5 mm,
use the cut off value of 240 for convenience.
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excluding the pathological myopic eyes which manifest maculop-
athy in early age, late stage AMD would show a strong positive
association with longer AL and also high OR. It is probably because
highly myopic eyes were excluded from our reﬁned study group
that there was a distinct increase in the proportion of late AMD in
eyes with long AL. Besides, we deﬁned long AL as >25 mm ac-
cording to themeanþ 1 SD distribution rather than using RE <1.0
Diopter (D) (used in most cross-section population-based studies)
because RE can be highly affected by other ocular parameters such
as cataracts, lens elasticity, cornea curvature, media clarity, and the
ability of ciliary muscle regulation. Our study supported that it is AL
that indeed has a direct inﬂuence on choroidal thickness and hence
on the choroidal circulatory function, resulting in the progress of
late AMD.
Furthermore, the analysis of the combination of both long AL
and thinner choroidal thickness showed even higher OR (9.57) for
late AMD (c2 ¼ 18.07, p < 0.001; 95% CI, 3.38e27.12). This result
gave us a hint that longer AL is not only directly inﬂuencing
choroidal thickness but it also has an unignorable impact on the
development of late AMD. Because high myopic maculopathy and
late AMD share some similar clinical ﬁndings such as choroidal
neovascularization, they may have similar pathophysiology
involving subretinal structures. The stretching of ocular tissues in
myopia affects the hemodynamics of the choroids. This results in
diffuse choroidal thinning, and choroidal neovascularization is
more likely to develop. The major difference is that high myopic
maculopathy happens earlier in young adults. The long AL combing
thinner choroids causing the less efﬁcient choroidal blood circula-
tion may explain why the pathological transformation occurs
earlier in these highly myopic eyes. However, although having a
long AL, eyes with a relative efﬁcient choroidal blood supply could
be sheltered from such pathological changes when they are young.
However, they are more likely to develop AMD when the choroids
become thinner and thinner and then circulation deteriorates as
they age. It is especially important in Asian countries where the
prevalence of myopia is disturbingly high.
5. Conclusion
This study was based on our previous study and the advantage
of this study is that it is a near population-based case-control study
of large scale.
Thinner SFCT is found to be related to the degree of AMD by
others and our researches, and longer AL is regarded as an impor-
tant factor of thinner choroidal thickness. Our study is the largest
population-based study comparing both the effect of SFCT and AL
together in Asian AMD patients. It is the ﬁrst one to reveal the in-
dependent high OR of SFCT and AL for late AMD and an even higher
OR when both come together (9.57, p < 0.001). The results gave us a
hint that longer AL not only directly inﬂuences choroidal thickness
but also has an unignorable impact on the development of late
AMD. These ﬁndings illustrate the crucial pathophysiological role of
these two factors and also arouse our attention to patients with
both characteristics.
Being a cross-sectional study, however, it is still difﬁcult to tell
whether decreased choroidal thickness is an inﬂuential factor for
the development of late AMD or if it is just a morphological change
as a result of senile degeneration. Further long-term cohort studies
comparing the progression and accumulative incidence of AMD in
patients with different AL, choroidal thickness, and even choroidal
circulation status using advanced devices, such as angiography
OCT,38 with a standard and automatic measurement process is
needed to clarify these issues.References
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